109688 ⎘
dsDNA viruses; Details; Adenoviridae; Mastadenovirus, e.g. human or simian adenoviruses Methods of production or purification of viral material
Sub-classes:MEANS FOR GENERATING ADENOVIRAL VECTORS FOR CLONING LARGE NUCLEIC ACIDS
#2METHOD FOR THE PURIFICATION OF RECOMBINANT ADENOVIRUS VECTORS
#3VIRAL VECTOR ASSAY AND VECTOR
#4EGFR VACCINE CASSETTES
#5Large Pore Agarose
#6CTA VACCINE CASSETTES
#7STABILIZED FORMULATIONS OF CHIMPANZEE ADENOVIRUS
#8VECTOR FOR CANCER TREATMENT
#9ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT VIRAL PARTICLES
#10IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#11VIRUS
#12COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION
#13COMPOSITIONS AND METHODS FOR ENHANCING PRODUCTION, GROWTH, SPREAD, OR ONCOLYTIC AND IMMUNOTHERAPEUTIC EFFICACY OF INTERFERON-SENSITIVE VIRUSES
#14IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#15METHODS FOR INDUCING AN IMMUNE RESPONSE VIA BUCCAL AND/OR SUBLINGUAL ADMINISTRATION OF A VACCINE
#16Immunogenic compositions and uses thereof
#17Analytical ultracentrifugation for characterization of recombinant viral particles
#18Analytical ultracentrifugation for characterization of recombinant viral particles
#19METHOD FOR PRODUCING VIRUS
#20GORILLA ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREOF
#21CELL LINE FOR USE IN PRODUCING RECOMBINANT ADENOVIRUSES
#22Analytical ultracentrifugation for characterization of recombinant viral particles
#23GENERATION OF DIVERSE VIRAL LIBRARIES
#24RAPID VERIFICATION OF VIRUS PARTICLE PRODUCTION FOR A PERSONALIZED VACCINE
#25VECTOR FOR CANCER TREATMENT
#26ADENOVIRAL ASSEMBLY METHOD
#27METHODS FOR PRODUCING PREPARATIONS OF RECOMBINANT AAV VIRIONS SUBSTANTIALLY FREE OF EMPTY CAPSIDS
#28METHODS OF PREPARING VIRAL VECTORS
#29METHOD OF PURIFYING A COMPOSITION COMPRISING A GROUP B ADENOVIRUS
#30Compositions and methods for viral sensitization
#31METHODS OF PURIFYING ADENOVIRUS
#32Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
#33Efficient Impurity Removal Using A Diafiltration Process
#34Viral vector assay and vector
#35Large Pore Agarose
#36METHODS AND COMPOSITIONS FOR PRODUCING A VIRUS
#37Rapid verification of virus particle production for a personalized vaccine
#38Stable, spray dried, immunogenic, viral compositions
#39Compositions and methods for viral sensitization
#40Immunogenic compositions and uses thereof
#41Compositions and methods for enhancing production, growth, spread, or oncolytic and immunotherapeutic efficacy of interferon-sensitive viruses
#42METHODS FOR INDUCING AN IMMUNE RESPONSE VIA BUCCAL AND/OR SUBLINGUAL ADMINISTRATION OF A VACCINE
#43Analytical ultracentrifugation for characterization of recombinant viral particles
#44Methods for producing preparations of recombinant AAV virions substantially free of empty capsids
#45ADENOVIRAL ASSEMBLY METHOD
#46Viral vector production system
#47MEANS FOR GENERATING ADENOVIRAL VECTORS FOR CLONING LARGE NUCLEIC ACIDS
#48NOVEL RECOMBINANT ADENO-ASSOCIATED VIRUS CAPSIDS WITH ENHANCED HUMAN SKELETAL MUSCLE TROPISM
#49Virus
#50LYSIS, EXTRACTION AND PURIFICATION OF ADENO-ASSOCIATED VIRUS AND ADENOVIRUS FROM HOST CELLS
#51Viral vector assay and vector
#52Stable, spray dried, immunogenic, viral compositions
#53Immunogenic compositions and uses thereof
#54STABILISATION OF VIRAL PARTICLES
#55PRODUCTION OF VIRAL VECTORS
#56Enhanced thermal stability for adenoviral vectors through spray drying
#57Immunogenic compositions and uses thereof
#58Compositions and kits for purification of viral particles from host cells
#59Analytical ultracentrifugation for characterization of recombinant viral particles
#60Human type 55 replication defective adenovirus vector, method for preparing same and uses thereof
#61Stable, Spray Dryed, Immunogenic, Viral Compositions
#62Compositions and methods for viral sensitization
#63Stable, Spray Dryed, Immunogenic, Viral Compositions
#64Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
#65Production of viral vectors
#66Recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
#67Targeted adenoviruses and methods of making, isolating, and using
#68PROCESS FOR THE PREPARATION OF GROUP B ADENOVIRUSES
#69Method of making adenovirus and corresponding plasmids
#70Excipients for stabilising viral particles, polypeptides or biological material
#71Immunogenic compositions and uses thereof
#72Stable aqueous formulations of adenovirus vectors
#73Adenoviral assembly method
#74Stable aqueous formulations of adenovirus vectors
#75Adenovirus producing novel cell line and the use thereof
#76Production of viral vectors
#77Stabilisation method for viruses or bacteria
#78Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
#79Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof
#80Adenoviral assembly method
#81Stabilisation of viral particles
#82METHODS AND COMPOSITIONS FOR THE PRODUCTION OF RECOMBINANT VIRUS VECTORS
#83Chimpanzee adenovirus vaccine carriers
#84Process for adenovirus purification from high cell density cultures
#85Method for the purification of adenovirus particles
#86Methods for producing preparations of recombinant AAV virions substantially free of empty capsids
#87COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS
#88Stable, spray dryed, immunogenic, viral compositions
#89METHOD FOR PRODUCING VIRUS FROM CELL CULTURE INVOLVING HOMOGENIZATION
#90Cell line from rousettus as host cell for pathogen amplification
#91Methods and compositions for the production of recombinant virus vectors
#92MODIFICATION OF NUCLEIC ACID VECTORS WITH POLYMERS COMPRISING CHARGED QUATERNARY AMINO GROUPS
#93MODIFICATION OF NUCLEIC ACID VECTORS WITH POLYMERS COMPRISING CHARGED QUATERNARY AMINO GROUPS
#94Chimpanzee adenovirus vaccine carriers
#95Method for the production of adenoviral vectors
#96Production of viral vectors
#97SYN3 compositions and methods
#98PURIFICATION OF ADENOVIRUS AND AAV
#99Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof
#100APPARATUS FOR THE DISRUPTION OF ANIMAL CELLS
#101Generation of oncolytic adenoviruses and uses thereof
#102Method for the production and purification of adenoviral vectors
#103METHOD FOR THE PRODUCTION AND PURIFICATION OF RETROVIRAL VECTORS
#104SYSTEM FOR RAPID PRODUCTION OF HIGH-TITER AND REPLICATION-COMPETENT ADENOVIRUS-FREE RECOMBINANT ADENOVIRUS VECTORS
#105Recombinant adenoviruses preparation and adenovirus banks
#106Compositions comprising viruses and methods for concentrating virus preparations
#107Adenoviral vectors for influenza virus production
#108Stocks of replication-deficient adenovirus
#109CHROMATOGRAPHIC METHODS FOR ASSESSING ADENOVIRUS PURITY
#110COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS
#111COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS
#112Compositions comprising viruses and methods for concentrating virus preparations
#113Packaging systems for human recombinant adenovirus to be used in gene therapy
#114Cell strain capable of being cultured without ingredients derived from animals, method of producing the same, method of producing virus using the same, and method of producing vaccine
#115Compositions Comprising Viruses and Methods for Concentrating Virus Preparations
#116Methods of adenovirus purification
#117Liquid adenovirus formulations
#118Formulation for adenovirus storage
#119Compositions comprising viruses and methods for concentrating virus preparations
#120Method for the production and purification of adenoviral vectors
#121Protamine-Adenoviral Vector Complexes and Methods of Use
#122Novel methods for ester detoxication
#123Porous silicon materials and devices
#124Methods for producing preparations of recombinant AAV virions substantially free of empty capsids
#125Apparatus for the Disruption of Animal Cells
#126Viral vector driven mutant bacterial cytosine deaminase gene and uses thereof
#127Methods for the Production and Purification of Adenoviral Vectors
#128Method for the production and purification of adenoviral vectors
#129Preservative-containing virus formulations
#130Recombinase-Based System for Expression of Foreign Proteins Using Adenovirus Vectors
#131Enhanced first generation adenovirus vaccines expressing condon optimized HIV1-Gag, Pol, Nef and modifications
#132Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications
#133Novel method for the protection and purification of adenoviral vectors
#134Packaging systems for human recombinant adenovirus to be used in gene therapy
#135Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
#136Formulations for therapeutic viruses having enhanced storage stability
#137Cells expressing recombinase useful for adenovirus vector production and control of gene expression
#138Method for purifying adenoviruses
#139Regulation of adenovirus DNA packaging by IPTG
#140Compositions comprising viruses and methods for concentrating virus preparations
#141Method for producing recombinant adenovirus
#142Vectors and methods for gene transfer
#143Packaging systems for human recombinant adenovirus to be used in gene therapy
#144Compositions comprising viruses and methods for concentrating virus preparations
#145Purification of adenovirus and AAV
#146Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
#147Methods of adenovirus purification
#148Adenovirus formulations
#149Methods of adenovirus production
#150Formulation of adenovirus for gene therapy
#151Methods and compositions for the production of adenoviral vectors
#152Methods of adenovirus purification
#153Method for the production and purification of adenoviral vectors
#154Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications
#155Methods for producing preparations of recombinant AAV virions substantially free of empty capsids
#156Device for cultivating cells and propagating viruses
#157Method for purifying virus